Helix Nanotechnologies YCアプリケーション

Winter 2017Active

Helix NanotechnologiesはWinter 2017バッチでHealthcare企業としてY Combinatorを卒業しました。以下：会社の事業内容、創業者、そして実際のYCフォームで質問ごとに再構築されたYCへの応募内容。

YCバッチ: Winter 2017
業界: HealthcareDrug Discovery and Delivery
チーム規模: 22
ステータス: Active
ローンチ済み: 2016

創業者

Nikolai EroshenkoFounder/CSO

Helix Nanotechnologiesの事業内容

Technology finds information and delivers physical products to us almost instantly. mRNA does the same for biology. At HelixNano, we see a world where treatments are cheap, progress is decentralized, and you can modify biology at the push of a button. By focusing on mRNA improvements from first principles, we’re getting there faster than we thought. Experiments that used to take months or years can be done in weeks and cost thousands instead of millions. The rate limiting step for our progress is now scientific curiosity. Rigid hierarchies and top-down decisions will miss the magic. Some of our most powerful technologies started out as side projects of junior team members. At HelixNano, every individual scientist can have a massive impact on the company's direction. And the more diverse our team, the faster we’ll find the really cool ideas. We've started rolling out some of our new tech - moving a COVID-19 vaccine candidate for the immunocompromised towards the clinic, and testing an intervention with massive environmental impact. But we’re scientists at heart, and team focus is solidly on the horizon.

Helix NanotechnologiesのYCアプリケーション、再構築済み

Y Combinator 申請

Helix Nanotechnologies 様、Winter 2017 バッチ。公開データから回答された、実際のフォームの質問。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Helix Nanotechnologies

Describe what your company does in 50 characters or less.

Next-generation mRNA platform for disease and climate

What is your company going to make? Please describe your product and what it does or will do.

We are building an mRNA platform that improves the speed and cost of developing therapies. Our technology allows experiments that once took months or years to be done in weeks, and for thousands of dollars instead of millions. We are advancing a COVID-19 vaccine candidate for the immunocompromised and testing an intervention aimed at climate impact.

Where do you live now, and where would the company be based after YC?

We live and work in Boston and Cambridge, MA, and will base the company there after YC.

Explain your decision regarding location.

Boston and Cambridge are biotech hubs with deep scientific talent and collaborators. Being here helps us attract the right team and stay on the cutting edge of RNA technology.

フルアプリケーションで21件の追加回答

はフルバージョンにあります。無料アカウントを作成して、他のすべてのYCバッチの横にあるYCインサイトで開いてください。

申請内容全体を見る

よくある質問

Helix Nanotechnologiesの実際のYCアプリケーションですか？

いいえ。Y Combinatorは提出されたアプリケーションを非公開にしています。これは再構築されたものです。実際のYCフォームの質問に、Helix Nanotechnologiesの公開データ（ローンチノート、創業者経歴、製品説明）から回答しています。Helix Nanotechnologiesのような会社がYCにどのようにアピールするかを示しており、彼らが提出したテキストではありません。